International Drug Monitoring Programme - WHO

Brazil was admitted into the World Health Organization (WHO) as the 62th country to be part of the International Monitoring Programme coordinated by the Uppsala Monitoring Centre - WHO Collaborating Centre for International Drug Monitoring, that takes place in Sweden. Below you can find the official communication that was sent from the WHO to the Ministry of Health in Brazil.

Official communication: http://www.anvisa.gov.br/farmacovigilancia/programa.htm